DERMATA THERAPEUTICS, INC. (DRMA) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 1.14 and resistance at 1.41. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control. Pattern invalidation sits near 1.08, so a violation there would materially change the current setup narrative.

📊 Technical Summary

The latest close for DERMATA THERAPEUTICS, INC. (DRMA) came in at 1.37 (+8.73%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +14.17%, with price is trading in the lower part of its roughly 52-week range (1.14–9.08), while ATR14 volatility is elevated at roughly 6.94% of price. RSI(14) is 55.1, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Near-term structure is defined by support at 1.14 and resistance at 1.41. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Net income: -1.69M · EPS (basic): -1.65. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more